https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Approves Expanded Indication to Tocilizumab-Anoh IV for CRS

FDA Approves Expanded Indication to Tocilizumab-Anoh IV for CRS

The FDA expands tocilizumab-anoh’s approval for treating cytokine release syndrome (CRS), enhancing treatment options for patients aged 2 and older.

administrator

Related Articles